All In Biotech

Drug Trial Radar · NCT06074562

A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Last checked: Nov 20, 2026Latest source record: Jul 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 404 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

404

Actual

Start

Oct 5, 2023

Primary completion

Jun 11, 2025

Study completion Jun 11, 2025

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Oct 10, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to determine the safety and efficacy of LY3556050 versus placebo in participants with diabetic peripheral neuropathic pain (DPNP). The study will lasts approximately 24 weeks, across 3 study periods.

Conditions

  • Diabetic Peripheral Neuropathy

Interventions

  • MazisotineDrug

    Administered orally.

  • PlaceboDrug

    Administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change From Baseline in Average Pain Intensity (API) as Measured by Weekly Average of Numeric Rating Scale (NRS) - Bayesian Model Averaging (BMA) Dose-response ModelTime frame: Baseline, Week 12
  2. Mean Change From Baseline in Average Pain Intensity (API) as Measured by Weekly Average of Numeric Rating Scale (NRS) - Frequentist Repeated Measures (FRM) AnalysisTime frame: Baseline, Week 12

Locations

70 sites in 5 countries. Site status is shown where the registry gives one.

  • The Institute for Liver Health II dba Arizona Clinical Trials - Mesa

    Chandler, Arizona

  • Headlands Research - Scottsdale

    Scottsdale, Arizona

  • Orange Grove Family Practice

    Tucson, Arizona

  • Preferred Research Partners

    Little Rock, Arkansas

  • Hope Clinical Research, Inc.

    Canoga Park, California

  • Valley Clinical Trials, Inc.

    Northridge, California

  • Northern California Research - Sacramento

    Sacramento, California

  • CMR of Greater New Haven, LLC

    Hamden, Connecticut

  • Suncoast Research Group

    Miami, Florida

  • New Horizon Research Center

    Miami, Florida

  • Northwestern University

    Chicago, Illinois

  • Alliance for Multispecialty Research, LLC

    Wichita, Kansas

  • Alliance for Multispecialty Research, LLC

    Lexington, Kentucky

  • Care Access - Lake Charles

    Lake Charles, Louisiana

  • MedVadis Research Corporation

    Waltham, Massachusetts

  • SKY Integrative Medical Center/SKYCRNG

    Ridgeland, Mississippi

  • StudyMetrix Research

    City of Saint Peters, Missouri

  • Alliance for Multispecialty Research, LLC

    Kansas City, Missouri

  • Clinvest Research LLC

    Springfield, Missouri

  • Las Vegas Medical Research

    Las Vegas, Nevada

  • UniMed Center

    East Brunswick, New Jersey

  • North Suffolk Neurology

    Port Jefferson Station, New York

  • Lucas Research - Hickory

    Hickory, North Carolina

  • Lucas Research, Inc

    Morehead City, North Carolina

  • Velocity Clinical Research, Medford

    Medford, Oregon

  • Tristar Clinical Investigations

    Philadelphia, Pennsylvania

  • Suburban Research Associates

    West Chester, Pennsylvania

  • New Phase Research and Development

    Knoxville, Tennessee

  • FutureSearch Trials of Neurology

    Austin, Texas

  • Juno Research

    Houston, Texas

  • Consano Clinical Research, LLC

    Shavano Park, Texas

  • Velocity Clinical Research, Salt Lake City

    West Jordan, Utah

  • Northwest Clinical Research Center

    Bellevue, Washington

  • Rainier Clinical Research Center

    Renton, Washington

  • Agentura Science Pro

    Olomouc, Czechia

  • EDUMED - Broumov

    Broumov, Hradec Králové Region, Czechia

  • Diabet2 s.r.o., diabetologicka a interni ambulance

    Prague, Praha 1, Czechia

  • Neurologická Ambulance - Forbeli

    Prague, Praha 6, Czechia

  • DiaVize s.r.o.

    Prague, Praha, Hlavní Mešto, Czechia

  • FLEDIP - Na dlouhem lanu

    Prague, Praha, Hlavní Mešto, Czechia

Showing 40 of 70 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.